Aurobindo Pharma gets USFDA approval for Ertapenem Injection Ruby Khatun Khatun27 Jun 2018 10:30 AM ISTHyderabad: Aurobindo Pharma Limited said it received final approval from the US Food and Drug Administration (USFDA) to manufacture and market...
SMT biodegradable polymer coated stent shows extra ordinary long term safety: seven-year clinical study Ruby Khatun Khatun27 Jun 2018 10:15 AM ISTMumbai: SMT (Sahajanand Medical Technologies Pvt. Ltd.), India’s largest manufacturer of cardiovascular medical stents, today, announced the...
Dementia venture fund raises 350 million dollar to hunt new drugs Ruby Khatun Khatun27 Jun 2018 9:45 AM ISTLONDON: A venture capital fund dedicated to finding new ways to prevent and treat dementia has raised $350 million, far exceeding the initial target...
Lilly's Jardiance meets main goal of two diabetes trials Ruby Khatun Khatun27 Jun 2018 9:30 AM ISTEli Lilly & Co said that its drug Jardiance, along with insulin therapy, met the main goal of two trials testing it in patients with type 1...
FDA approves first marijuana plant-derived drug for epilepsy Ruby Khatun Khatun26 Jun 2018 10:15 AM ISTThe U.S. Food and Drug Administration (FDA) approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two...
Clamor for GSK shingles shot points to bigger profits Ruby Khatun Khatun26 Jun 2018 10:00 AM ISTLONDON: GlaxoSmithKline (GSK) is facing “unprecedented” demand for its new shingles vaccine Shingrix, suggesting the product could be a bigger...
Pfizer's breast cancer drug combo falls short of survival goal Ruby Khatun Khatun26 Jun 2018 9:45 AM ISTPfizer Inc said a combination of its breast cancer drug, Ibrance, and another drug was not statistically significant in extending overall survival in...
Study preserves hopes for Roche's Tecentriq in lung cancer Ruby Khatun Khatun26 Jun 2018 9:30 AM ISTZURICH: Swiss drugmaker Roche’s hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form of lung...
Dr Reddy's loses patent case with Eli Lilly over Alimta Ruby Khatun Khatun25 Jun 2018 10:30 AM ISTDr Reddy's Laboratories Limited has lost a legal battle with Eli Lilly and Company in a patent litigation on Alimta (pemetrexed for injection), a drug...
Lupin to launch nearly 30 products in US market in FY18 Ruby Khatun Khatun25 Jun 2018 10:00 AM ISTNew Delhi: With rapid approvals from US health regulator anticipated, homegrown drug major Lupin sees the opportunity to launch around 30 generic...
Genkyotex expands license agreement for Vaxiclase platform with Serum Institute of India Ruby Khatun Khatun25 Jun 2018 9:45 AM ISTGenkyotex, a biopharmaceutical company and the leader in NOX therapies, announces that it has expanded the license agreement for its Vaxiclase...
US medical device firm electroCore IPO price set at 15 dollar per share Ruby Khatun Khatun25 Jun 2018 9:30 AM ISTU.S. medical device maker electroCore Inc’s initial public offering is expected to price at $15 per share, Chief Executive Officer Frank Amato told...
